Phase II trial of depsipeptide (NSC-630176) [romidepsin] in colorectal cancer patients who have received either one or two prior chemotherapy regimens for metastatic or locally advanced, unresectable disease
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2013
At a glance
- Drugs Romidepsin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 23 Aug 2005 New trial record.